These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26325308)

  • 21. Hepatic clearance of rat plasma intestinal alkaline phosphatase.
    Young GP; Rose IS; Cropper S; Seetharam S; Alpers DH
    Am J Physiol; 1984 Oct; 247(4 Pt 1):G419-26. PubMed ID: 6496679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel hypothesis for an alkaline phosphatase 'rescue' mechanism in the hepatic acute phase immune response.
    Pike AF; Kramer NI; Blaauboer BJ; Seinen W; Brands R
    Biochim Biophys Acta; 2013 Dec; 1832(12):2044-56. PubMed ID: 23899605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics following intravenous administration of recombinant human hepatocyte growth factor in rats with renal injury.
    Adachi E; Hirose-Sugiura T; Kato Y; Ikebuchi F; Yamashita A; Abe T; Fukuta K; Adachi K; Matsumoto K
    Pharmacology; 2014; 94(3-4):190-7. PubMed ID: 25378205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of recombinant human brain natriuretic peptide on acute renal injury induced by endotoxin in canines.
    Li N; Jin HX; Song Z; Bai CZ; Cui Y; Gao Y
    Cell Biochem Biophys; 2014 Nov; 70(2):1317-24. PubMed ID: 24943350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration.
    Haug KG; Weber B; Hochhaus G; Butterweck V
    Eur J Pharm Sci; 2012 Jan; 45(1-2):79-89. PubMed ID: 22085634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced acute kidney injury in a rat model of sepsis.
    Liu L; Song Y; Zhao M; Yi Z; Zeng Q
    Int Urol Nephrol; 2015 Oct; 47(10):1745-52. PubMed ID: 26300162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Göttingen minipig® as an alternative non-rodent species for immunogenicity testing: a demonstrator study using the IL-1 receptor antagonist anakinra.
    van Mierlo GJ; Cnubben NH; Kuper CF; Wolthoorn J; van Meeteren-Kreikamp AP; Nagtegaal MM; Doornbos R; Ganderup NC; Penninks AH
    J Immunotoxicol; 2013; 10(1):96-105. PubMed ID: 23134195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
    Rensen PC; Oosten M; Bilt E; Eck M; Kuiper J; Berkel TJ
    J Clin Invest; 1997 May; 99(10):2438-45. PubMed ID: 9153287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine intestinal alkaline phosphatase attenuates the inflammatory response in secondary peritonitis in mice.
    van Veen SQ; van Vliet AK; Wulferink M; Brands R; Boermeester MA; van Gulik TM
    Infect Immun; 2005 Jul; 73(7):4309-14. PubMed ID: 15972524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supplemented Alkaline Phosphatase Supports the Immune Response in Patients Undergoing Cardiac Surgery: Clinical and Computational Evidence.
    Presbitero A; Mancini E; Brands R; Krzhizhanovskaya VV; Sloot PMA
    Front Immunol; 2018; 9():2342. PubMed ID: 30364262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alkaline phosphatase reduces hepatic and pulmonary injury in liver ischaemia -- reperfusion combined with partial resection.
    van Veen SQ; Dinant S; van Vliet AK; van Gulik TM
    Br J Surg; 2006 Apr; 93(4):448-56. PubMed ID: 16491472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human tissue non-specific alkaline phosphatase successfully counteracts lipopolysaccharide induced sepsis in mice.
    Bender B; Baranyi M; Kerekes A; Bodrogi L; Brands R; Uhrin P; Bösze Z
    Physiol Res; 2015; 64(5):731-8. PubMed ID: 25804104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
    Badger CC; Davis J; Nourigat C; Wu ZM; Hui TE; Fisher DR; Shulman H; Appelbaum FR; Eary JF; Krohn KA
    Cancer Res; 1991 Nov; 51(21):5921-8. PubMed ID: 1682038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of human pharmacokinetics and tissue distribution of apicidin, a potent histone deacetylase inhibitor, by physiologically based pharmacokinetic modeling.
    Shin BS; Bulitta JB; Balthasar JP; Kim M; Choi Y; Yoo SD
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):465-75. PubMed ID: 21069337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
    Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
    Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microdosing of a Carbon-14 Labeled Protein in Healthy Volunteers Accurately Predicts Its Pharmacokinetics at Therapeutic Dosages.
    Vlaming ML; van Duijn E; Dillingh MR; Brands R; Windhorst AD; Hendrikse NH; Bosgra S; Burggraaf J; de Koning MC; Fidder A; Mocking JA; Sandman H; de Ligt RA; Fabriek BO; Pasman WJ; Seinen W; Alves T; Carrondo M; Peixoto C; Peeters PA; Vaes WH
    Clin Pharmacol Ther; 2015 Aug; 98(2):196-204. PubMed ID: 25869840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
    Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
    Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
    Akizuki S; Mizorogi F; Inoue T; Sudo K; Ohnishi A
    Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. coli L-asparaginase preparation (MC0609) in Beagle dog.
    Borghorst S; Hempel G; Poppenborg S; Franke D; König T; Baumgart J
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):367-78. PubMed ID: 24934864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.